Clinical Trial Update: Sealing Moderate Coronary Saphenous VEin Graft Lesions With Paclitaxel-Eluting Stents [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating sealing moderate saphenous vein graft lesions with paclitaxel-eluting stents in patients with prior coronary bypass surgery was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Paclitaxel-eluting stent (paclitaxel-eluting stent)

Snippet

Sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | Conditions: Coronary Artery Bypass Grafting | Phase 4 | Status: TERMINATED